supported by grants from the Start-up Foundation of Tsinghua University(No.400-53332101822);the Tsinghua-Peking Center for Life Sciences(No.045-61000100122);the National Key R&D Program of China(Nos.2021YFC2301900 and 2021YFC2301905);the National Natural Science Foundation of China(Nos.32200036 and 81974303);the Beijing Natural Science Foundation(Nos.L222068 and Z220018);the High-Level Public Health Specialized Talents Project of Beijing Municipal Health Commission(No.2022-2-018);the Beijing Key Laboratory for HIV/AIDS Research(No.BZ0089)
Over the past few years,the human virome and its complex interactions with microbial communities and the immune system have gained recognition as a crucial factor in human health.Individuals with compromised immune fu...
supported by the National Key R&D Program of China(No.2021YFC2301900-2021YFC2301901)
With the development of combination antiretroviral therapy(cART),human immunodeficiency virus(HIV)infection has transitioned from a generally fatal disease to a manageable chronic condition over the past two decades.[...
Shanghai Science and Technology Committee(No.19YF1441300);Shanghai Municipal Health Commission(No.20184Y0007);Shenzhen High-level Hospital Construction Fund(Nos.G2021027 and G2022062)
To the Editor:Human immunodeficiency virus(HIV)type 1 infection remains a serious and intractable public health problem worldwide.In 2020,there were 37.7 million surviving individuals with HIV infection worldwide and ...
This work was funded by grants from the Tianjin Key Medical Discipline (Specialty) Construction Project (No. ZD02);the Tianjin Science and Technology Cultivation Project (No. RC20019)。
To the Editor:With recent advances in antiretroviral therapy(ART)regimens,many patients may benefit from switching drugs.The new combination drug,elvitegravir/cobicistat/emtricitabine/tenofovir(E/C/F/TAF),has been app...
Co-Sponsored Construction Project of Provincial Medicine and Technique of Henan Province(No. LHGJ20191103)。
To the Editor:Even with the emergence of highly active antiretroviral therapy,human immunodeficiency virus type 1(HIV-1)remains a serious public health problem worldwide.The widespread use of antiretroviral therapy(AR...
Key Research and Development Project, Department of Science and Technology, Sichuan Province(Nos. 2018SZ0212 and 2018JY0383);Fundamental Research Funds for the Central Universities, Project of Sichuan Health and Family Planning Commission(No. 18PJ015)
To the Editor:There have been growing concerns about the gut bacterial dysbiosis associated with HIV infection,addressing a critical role of gut bacteria in persistent chronic inflammation and severe intestinal dysfun...
the Shanghai Commission of Science and Technology(No.20MC1920100).
Nontuberculous mycobacteria(NTM)infection can occur in both immunocompetent and immunocompromised patients,but disseminated NTM infection is mostly occurred in immunocompromised patients such as people using long-term...
the Mega-Projects of National Science Research for the 13th Five-Year Plan(No.2017ZX10201101);the National Natural Science Foundation of China(No.82073620).
Human immunodeficiency virus(HIV)testing is the only way to find people living with HIV(PLWH).Early diagnosis and early treatment of HIV can extend the life of PLWH and reduce the subsequent transmission of HIV.Theref...
Human immunodeficiency virus/acquired immunodeficiency syndrome(HIV/AIDS)is still a threat to global public health,with around 38 million people living with HIV by the end of 2019(http://www.unaids.org).Until now,ther...
The work was supported by a grant from the Mega-Projects of National Science Research for the 13th Five-Year Plan(No.2017ZX10201101)。
To eliminate the public health threat of the global human immunodeficiency virus infection and acquired immune deficiency syndrome(HIV/AIDS)epidemic by 2030,the Joint United Nations Programme on HIV/AIDS launched 90-9...